Brief: Cytodyn Files Priority Review Request Of BLA For First Approval
01/06/2020 11:15
June 1 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN FILES REQUEST WITH FDA FOR PRIORITY REVIEW OF BLA
FOR
FIRST APPROVAL
Source text for Eikon: ID:nGNX1tx2rG
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer